BRCA1 signals ARF-dependent stabilization and coactivation of p53
Open Access
- 11 November 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (47), 6605-6614
- https://doi.org/10.1038/sj.onc.1203284
Abstract
The hereditary breast and ovarian tumor suppressor BRCA1 can activate p53-dependent gene expression. We show here that BRCA1 increases p53 protein levels through a post-transcriptional mechanism. BRCA1-stabilized p53 has increased sequence-specific DNA-binding and transcriptional activity. BRCA1 does not stabilize p53 in p14ARF-deficient cells. A deletion mutant of BRCA1 which inhibits p53-dependent transcription confers resistance to topoisomerase II-targeted chemotherapy. Our results suggest that BRCA1 may trigger the p53 pathway through two potentially separate mechanisms: accumulation of p53 through a direct or indirect induction of p14ARF as well as direct transcriptional coactivation of p53. BRCA1 may also enhance chemosensitivity and repair of DNA damage through binding to and coactivation of p53.Keywords
This publication has 35 references indexed in Scilit:
- p14ARF links the tumour suppressors RB and p53Nature, 1998
- Regulation ofp53downstream genesSeminars in Cancer Biology, 1998
- Transcriptional activation by BRCA1Nature, 1996
- In vitro evaluation of ap53-expressing adenovirus as an anti-cancer drugInternational Journal of Cancer, 1996
- E2F-1 Functions in Mice to Promote Apoptosis and Suppress ProliferationCell, 1996
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- Transcriptional control by E2FSeminars in Cancer Biology, 1995
- BRCA1 Mutations in Primary Breast and Ovarian CarcinomasScience, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53Science, 1990